BDRX Stock Summary and Trading Ideas (Biodexa Pharmaceuticals PLC - American Depositary Shares | NASDAQ:BDRX)

Biodexa Pharmaceuticals PLC is a drug delivery technology company focused on improving the bio-delivery and bio-distribution of medicines. The company combines approved and developed medications with its proprietary and drug delivery technologies to provide compelling products that have the potential to powerfully impact the lives of patients.

Biodexa Pharmaceuticals PLC - American Depositary Shares trades on the NASDAQ stock market under the symbol BDRX.

As of December 20, 2024, BDRX stock price declined to $3.99 with 21,536 million shares trading.

BDRX has a beta of 4.46, meaning it tends to be more sensitive to market movements. BDRX has a correlation of 0.16 to the broad based SPY ETF.

BDRX has a market cap of $57.94 million. This is considered a Micro Cap stock.

BDRX has underperformed the market in the last year with a price return of -93.9% while the SPY ETF gained +27.8%. BDRX has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -45.4% and -18.1%, respectively, while the SPY returned +4.4% and -2.4%, respectively.

BDRX support price is $3.57 and resistance is $4.43 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that BDRX shares will trade within this expected range on the day.